AMGEVITA 40 mg solution for injection in pre-filled syringe

DRUG2 trials

Sponsors

Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University Hospital, Centre Hospitalier Universitaire Amiens Picardie

Conditions

Rheumatoid arthritisulcerative colitis

Phase 3

IMPACT OF ANTI-TNF, VEDOLIZUMAB AND TOFACITINIB ON AORTIC STIFFNESS, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK OF PATIENTS WITH ULCERATIVE COLITIS

Not yet recruitingCTIS2024-517314-15-00

Centre Hospitalier Universitaire Amiens Picardieulcerative colitis

Target: 100Updated: 2024-09-10

Phase 4

A multi-center, open, randomized, 18-month, parallel-group, superiority study to compare the effect of proactive therapeutic drug monitoring versus standard of care with regards to maintenance of sustained disease control without flare in adults with rheumatoid arthritis treated with a subcutaneous tumor necrosis factor inhibitor

RecruitingCTIS2023-510184-35-00

Diakonhjemmet Sykehus AS, University Of Medicine And Pharmacy Carol Davila Bucharest, Medical University Of Vienna, Karolinska University HospitalRheumatoid arthritis

Start: 2024-08-20Target: 410Updated: 2025-09-12